Back
Palisade Bio, Inc. Vs. Nebius Group NV Industry Stock Comparison
Sell
27
PALI
Palisade Bio, Inc.
Last Price:
$1.66
Seasonality Move:
-1.59%
Sell
24
NBIS
Nebius Group NV
Last Price:
$78.06
Seasonality Move:
-2.57%
Sell
27
Palisade Bio, Inc. (PALI)
is a Sell
Is Palisade Bio, Inc. a Buy, Sell or Hold?
-
The current Palisade Bio, Inc. [PALI] share price is $1.68. The Score for PALI is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
PALI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
24
Nebius Group NV (NBIS)
is a Sell
Is Nebius Group NV a Buy, Sell or Hold?
-
The current Nebius Group NV [NBIS] share price is $75.45. The Score for NBIS is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
-
NBIS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PALI Stock Price Chart
What is Palisade Bio, Inc.'s stock price today?
-
The Palisade Bio, Inc. share price today is $1.68Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PALI is experiencing selling pressure, which indicates risk of future bearish movement.
NBIS Stock Price Chart
What is Nebius Group NV's stock price today?
-
The Nebius Group NV share price today is $75.45Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBIS is experiencing selling pressure, which indicates risk of future bearish movement.
PALI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.13 | Buy |
| Relative Strength Index (14 RSI): | 42.8 | Sell |
| Chaikin Money Flow: | -2101305 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.8 - 2.18) | Sell |
| Bollinger Bands (100): | (0.79 - 1.97) | Buy |
NBIS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -5.2 | Sell |
| Relative Strength Index (14 RSI): | 33.15 | Sell |
| Chaikin Money Flow: | -16309860 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (84.38 - 98.22) | Sell |
| Bollinger Bands (100): | (70.89 - 115.77) | Sell |
PALI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.9 | Sell |
| 20-day SMA: | 1.98 | Sell |
| 50-day SMA: | 1.91 | Sell |
| 200-day SMA: | 1.07 | Buy |
| 8-day EMA: | 0.37 | Buy |
| 20-day EMA: | 0.16 | Buy |
| 50-day EMA: | 0.07 | Buy |
| 200-day EMA: | 0.02 | Buy |
NBIS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 88.73 | Sell |
| 20-day SMA: | 91.98 | Sell |
| 50-day SMA: | 104.73 | Sell |
| 200-day SMA: | 64.65 | Buy |
| 8-day EMA: | 86.03 | Sell |
| 20-day EMA: | 91.96 | Sell |
| 50-day EMA: | 96.52 | Sell |
| 200-day EMA: | 73.39 | Buy |
Palisade Bio, Inc. Earnings Growth & PALI Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $11.02 per share, and an increase next year of $0.45 per share.
Nebius Group NV Earnings Growth & NBIS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.56 per share.
Palisade Bio, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nebius Group NV Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||